Development and Characterization of a Stable Epithelial Cell Line from Muta™Mouse Lung

Environmental and Molecular Mutagenesis

Volumn 42, Issue 3, 2003, Pages 166-184

  White, Paul A ^a   Douglas, George R ^a   Gingerich, John ^a   Parfett, Craig ^a   Shwed, Phil ^a   Seligy, Vern ^a   Soper, Lynda ^a   Berndt, Lynn ^a   Bayley, Janet ^a   Wagner, Shelley ^a   Pound, Kathleen ^a   Blakey, David ^a  

^a HEALTH CANADA   (Canada)

Author keywords

Epithelium; In vitro; Mutagenesis; Sister chromatid exchanges; Transgenic

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; ALPHA NAPHTHOFLAVONE; BENZO[A]PYRENE; CYTOCHROME P450 1A1; CYTOKERATIN; ETHOXYRESORUFIN DEETHYLASE; ETHYLNITROSOUREA; GLUTATHIONE TRANSFERASE; VIMENTIN; XENOBIOTIC AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL IMMORTALIZATION; CELL LINE; CHROMOSOME ABERRATION; CONTROLLED STUDY; EPITHELIUM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENOME; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; MALE; MICRONUCLEUS; MOUSE; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; SISTER CHROMATID EXCHANGE; SLOT BLOT HYBRIDIZATION; TRANSGENE;

ANIMALS; EPITHELIAL CELLS; LAC OPERON; LUNG; MICE; MICE, MUTANT STRAINS; MICROSCOPY, FLUORESCENCE; MUTATION; TRANSGENES;

EID: 0242426437     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10185     Document Type: Article

References (92)

1. Ashby J, Tinwell H. 1994. Use of transgenic mouse lacI/Z mutation assays in genetic toxicology. Mutagenesis 9:179-181.
2. Blakey DH, Douglas GR, Huang KC, Winter HJ. 1995. Cytogenetic mapping of lambda gt10 lacZ sequences in the transgenic mouse strain 40.6 (Muta™Mouse). Mutagenesis 10:145-148.
3. Boobis AR, Lynch AM, Murray S, de la Torre R, Solans A, Farre M, Segura J, Gooderham NJ, Davies DS. 1994. CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. Cancer Res 54:89-94.
4. Broers JL, Carney DN, Klein Rot M, Schaart G, Lane EB, Vooijs GP, Ramaekers FC. 1986. Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies. J Cell Sci 83:37-60.
5. Buonarati MH, Turteltaub KW, Shen NH, Felton JS. 1990. Role of sulfation and acetylation in the activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine to intermediates which bind DNA. Mutat Res 245:185-190.
6. Carlson GP, Hynes DE, Mantick NA. 1998. Effects of inhibitors of CYP1A and CYP2B on styrene metabolism in mouse liver and lung microsomes. Toxicol Lett 98:131-137.
7. Chen WD, Eshleman JR, Aminoshariae MR, Ma AH, Veloso N, Markowitz SD, Sedwick WD, Veigl ML. 2000. Cytotoxicity and mutagenicity of frameshift-inducing agent ICR191 in mismatch repair-deficient colon cancer cells. J Natl Cancer Inst 92:480-485.
8. Claxton LD, Creason J, Leroux B, Agurell E, Bagley S, Bryant DW, Courtois YA, Douglas G, Clare CB, Goto S, Quillardet P, Jagannath DR, Kataoka K, Mohn G, Nielsen PA, Ong T, Pederson TC, Shimizu H, Nylund L, Tokiwa H, Vink GJ, Wang Y, Warshawsky D. 1992. Results of the IPCS collaborative study on complex mixtures. Mutat Res 276:23-32.
9. Crofts FG, Sutter TR, Strickland PT. 1998. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1. Carcinogenesis 19:1969-1973.
10. Dean B, Danford N. 1984. Assays for the detection of chemically-induced chromosome damage in cultured mammalian cells. In: Venitt S, Parry J, editors. Mutagenicity testing: a practical approach. Oxford: IRL Press. pp 187-232.
11. Dean SW, Myhr B. 1994. Measurement of gene mutation in vivo using Muta™Mouse and positive selection for lacZ-phage. Mutagenesis 9:183-185.
12. Devereux TR, Massey TE, Van Scott MR, Yankaskas J, Fouts JR. 1986. Xenobiotic metabolism in human alveolar type II cells isolated by centrifugal elutriation and density gradient centrifugation. Cancer Res 46:5438-5443.
13. DeVito MJ, Menache MG, Diliberto JJ, Ross DG, Birnbaum LS. 2000. Dose-response relationships for induction of CYP1A1 and CYP1A2 enzyme activity in liver, lung, and skin in female mice following subchronic exposure to polychlorinated biphenyls. Toxicol Appl Pharmacol 167:157-172.
14. Douglas G, Gingerich J, Soper L, MacMahon A, Foster W. 1999. Gene mutations in follicular granulosa cells of super-ovulated LacZ transgenic mice. Environ Mol Mutagen S30:23.
15. Douglas GR, Grant CE. 1980. DNA damage, cell survival and DNA repair in Chinese hamster ovary cells after in vitro metabolic activation of dimethylnitrosamine and benzo[a]pyrene. Mutat Res 77:259-269.
16. Douglas GR, Nestmann ER, Grant CE, Bell RD, Wytsma JM, Kowbel DJ. 1981. Mutagenic activity of diallate and triallate determined by a battery of in vitro mammalian and microbial tests. Mutat Res 85:45-56.
17. Douglas GR, Jiao J, Gingerich JD, Gossen JA, Soper LM. 1995. Temporal and molecular characteristics of mutations induced by ethylnitrosourea in germ cells isolated from seminiferous tubules and in spermatozoa of lacZ transgenic mice. Proc Natl Acad Sci USA 92:7485-7489.
18. Eaton DL, Bammler TK. 1999. Concise review of the glutathione-S-transferases and their significance to toxicology. Toxicol Sci 49: 156-164.
19. Erexson GL, Cunningham ML, Tindall KR. 1998. Cytogenetic characterization of the transgenic BigBlue® Rat2 and BigBlue® mouse embryonic fibroblast cell lines. Mutagenesis 13:649-653.
20. Erexson GL, Watson DE, Tindall KR. 1999. Characterization of new transgenic BigBlue® mouse and rat primary fibroblast cell strains for use in molecular toxicology studies. Environ Mol Mutagen 34:90-96.
21. Faruqi AF, Egholm M, Glazer PM. 1998. Peptide nucleic acid-targeted mutagenesis of a chromosomal gene in mouse cells. Proc Natl Acad Sci USA 95:1398-1403.
22. Felton JS, Knize MG, Dolbeare FA, Wu R. 1994. Mutagenic activity of heterocyclic amines in cooked foods. Environ Health Perspect 102:201-204.
23. Ferguson LR, Denny WA. 1990. Frameshift mutagenesis by acridines and other reversibly-binding DNA ligands. Mutagenesis 5:529-540.
24. Freshney R. 1998. Freshney's culture of animal cells: a multimedia guide. New York: John Wiley & Sons.
25. Gabbiani G, Kapanci Y, Barazzone P, Franke WW. 1981. Immunochemical identification of intermediate-sized filaments in human neoplastic cells. A diagnostic aid for the surgical pathologist. Am J Pathol 104:206-216.
26. Galloway SM, Armstrong MJ, Reuben C, Colman S, Brown B, Cannon C, Bloom AD, Nakamura F, Ahmed M, Duk S, Rimpo J, Margolin BH, Resnick MA, Anderson B, Zeiger Z. 1987. Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals. Environ Mol Mutagen 10:1-175.
27. Gossen JA, Vijg J. 1993. A selective system for lacZ-phage using a galactose-sensitive E. coli host. Biotechniques 14:326-330.
28. Gossen JA, de Leeuw WJ, Tan CH, Zwarthoff EC, Berends F, Lohman PH, Knook DL, Vijg J. 1989. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc Natl Acad Sci USA 86:7971-7975.
29. Gossen JA, Molijn AC, Douglas GR, Vijg J. 1992. Application of galactose-sensitive E. coli strains as selective hosts for LacZ-plasmids. Nucleic Acids Res 20:3254.
30. Goto S, Endo O, Matsushita H. 1992. Results of a comparative study on the Salmonella pre-incubation and plate incorporation assays using test samples from the IPCS collaborative study. Mutat Res 276:93-100.
31. Granberg AL, Brunstrom B, Brandt I. 2000. Cytochrome P450-dependent binding of 7,12-dimethylbenz[a]anthracene (DMBA) and benzo[a]pyrene. Arch Toxicol 74:593-601.
32. Habig WH, Jakoby WB. 1981. Assays for differentiation of glutathione-S-transferases. Methods Enzymol 77:398-405.
33. Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-7139.
34. Hayes JD, Judah DJ, McLellan LI, Neal GE. 1991. Contribution of the glutathione-S-transferases to the mechanisms of resistance to aflatoxin B1. Pharmacol Ther 50:443-472.
35. Hayes JD, Pulford DJ. 1995. The glutathione-S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445-600.
36. Hayflick L, Moorhead P. 1961. The serial cultivation of human diploid cell strains. Exp Cell Res 25:585-621.
37. Helsby NA, Chipman JK, Gescher A, Kerr D. 1998. Inhibition of mouse and human CYP 1A- and 2E1-dependent substrate metabolism by the isoflavonoids genistein and equol. Food Chem Toxicol 36:375-82.
38. Imaida K, Ogawa K, Takahashi S, Ito T, Yamaguchi T, Totsuka Y, Wakabayashi K, Tanaka K, Ito N, Shirai T. 2000. Delay of DNA-adduct repair and severe toxicity in xeroderma pigmentosum group A gene (XPA) deficient mice treated with 2-amino-1-methyl-6-phenyl-imidazo [4,5-b] pyridine (PhIP). Cancer Lett 150:63-69.
39. IPCS (International Program on Chemical Safety). 1998. Environmental Health Criteria 202. Selected non-heterocyclic polycyclic aromatic hydrocarbons. Geneva: World Health Organization. 883 p.
40. Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, Takayama S, Sugimura T. 1991. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 12:1503-1506.
41. Jaeschke H, Wendel A. 1985. Manipulation of mouse organ glutathione contents. I. Enhancement by oral administration of butylated hydroxyanisole and butylated hydroxytoluene. Toxicology 36:77-85.
42. Jakubczak JL, Merlino G, French JE, Muller WJ, Paul B, Adhya S, Garges S. 1996. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc Natl Acad Sci USA 93:9073-9078.
43. Jeffrey AM. 1985. DNA modification by chemical carcinogens. Pharmacol Ther 28:237-272.
44. Kalweit S, Utesch D, von der Hude W, Madle S. 1999. Chemically induced micronucleus formation in V79 cells-comparison of three different test approaches. Mutat Res 439:183-190.
45. Kleiner HE, Vulimiri SV, Miller L, Johnson WH Jr, Whitman CP, DiGiovanni J. 2001. Oral administration of naturally occurring coumarins leads to altered phase I and II enzyme activities and reduced DNA adduct formation by polycyclic aromatic hydrocarbons in various tissues of SENCAR mice. Carcinogenesis 22:73-82.
46. Kohler SW, Provost GS, Fieck A, Kretz PL, Bullock WO, Putman DL, Sorge JA, Short JM. 1991. Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector. Environ Mol Mutagen 18:316-321.
47. Lambert IB, Boucher SE, Bailey JM, Douglas GR. A relational database for the assessment of transgenic rodent assays. Environ Mol Mutagen (in preparation).
48. LeBoeuf RA, Kerchaert GA. 1987. Enhanced morphological transformation of early passage Syrian hamster embryo cells cultured in medium with a reduced bicarbonate concentration and pH. Carcinogenesis 8:689-697.
49. Lezon-Geyda K, Jaime CM, Godbold JH, Savransky EF, Hope A, Kheiri SA, Dzmura ZM, Uehara H, Johnson EM, Fasy TM. 1996. Chrysotile asbestos fibers mediate homologous recombination in Rat2 lambda fibroblasts: implications for carcinogenesis. Mutat Res 361: 113-120.
50. Lichtenauer-Kaligis EG, van der Velde-van Dijke I, den Dulk H, van de Putte P, Giphart-Gassler M, Tasseron-de Jong JG. 1993. Genomic position influences spontaneous mutagenesis of an integrated retroviral vector containing the hprt cDNA as target for mutagenesis. Hum Mol Genet 2:173-182.
51. Lipscomb JC, Garrett CM, Snawder JE. 1998. Use of kinetic and mechanistic data in species extrapolation of bioactivation: cytochrome P-450 dependent trichloroethylene metabolism at occupationally relevant concentrations. J Occup Health 40:110-117.
52. Malkinson AM, Dwyer-Nield LD, Rice PL, Dinsdale D. 1997. Mouse lung epithelial cell lines-tools for the study of differentiation and the neoplastic phenotype. Toxicology 123:53-100.
53. Masumura K, Matsui M, Katoh M, Horiya N, Ueda O, Tanabe H, Yamada M, Suzuki H, Sofuni T, Nohmi T. 1999. Spectra of gpt mutations in ethylnitrosourea-treated and untreated transgenic mice. Environ Mol Mutagen 34:1-8.
54. McDiarmid HM, Douglas GR, Coomber BL, Josephy PD. 2001. Epithelial and fibroblast cell lines cultured from the transgenic BigBlue® rat: an in vitro mutagenesis assay. Mutat Res 497:39-47.
55. McDiarmid HM, Douglas GR, Coomber BL, Josephy PD. 2002. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mutagenesis in cultured BigBlue rat mammary epithelial and fibroblast cells. Environ Mol Mutagen 39:245-253.
56. Mientjes E, vanDelft J, op'tHof B, Gossen J, Vijg J, Lohman P, Baan R. 1994. An improved selection method for LacZ-phages based on galactose sensitivity. Transgenic Res 5:67-68.
57. Mientjes EJ, Luiten-Schuite A, van der Wolf E, Borsboom Y, Bergmans A, Berends F, Lohman PH, Baan RA, van Delft JH. 1998. DNA adducts, mutant frequencies, and mutation spectra in various organs of lambda lacZ mice exposed to ethylating agents. Environ Mol Mutagen 31:18-31.
58. Moll R. 1994. Cytokeratins in the histological diagnosis of malignant tumors. Int J Biol Markers 9:63-69.
59. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. 1982. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24.
60. Moslen MT, Harper BL, Roy D. 1988. Effects of a cysteine precursor, L-2-oxothiazolidine-carboxylate, nutritional status, and sex on tissue glutathione and hepatic GSH-utilizing enzymes of CD-1 mice. Res Commun Chem Pathol Pharmacol 61:49-63.
61. NIST (National Institute of Standards and Technology). 1992. Certificate of analysis. Standard reference material 1597. Complex mixture of polycyclic aromatic hydrocarbons from coal tar. Gaithersburg, MD: NIST. 10 p.
62. OECD (Organization for Economic Cooperation and Development). 1999. OECD guidelines for testing of chemicals. Test guideline #476. In vitro mammalian cell gene mutation test. Paris: Environmental Health and Safety Division, OECD Environment Directorate. 10 p.
63. Papp-Szabó E, Douglas GR, Coomber BL, Josephy PD. 2002. Mutagenicity of the oral carcinogen 4-nitroquinoline-1-oxide in cultured BigBlue™ rat tongue cells and fibroblasts. Mutat Res 522:107-117.
64. Parkinson A. 2001. Biotransformation of xenobiotics. In: Klaassen C, editor. Casarett and Doull's toxicology. The basic science of poisons. 6th ed. New York: McGraw-Hill. p 133-224.
65. Pohl RJ, Fouts JR. 1980. A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal Biochem 107:150-155.
66. Prough RA, Burke MD, Mayer RT. 1978. Direct fluorometric methods for measuring mixed function oxidase activity. Methods Enzymol 52: 372-377.
67. Recio L, Steen A-M, Pluta LJ, Meyer KG, Saranko CJ. 2001. Mutational spectra of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms. Chem Biol Interact 135-136:325-341.
68. Rietjens IM, Dormans JA, Rombout PJ, van Bree L. 1988. Qualitative and quantitative changes in cytochrome P-450-dependent xenobiotic metabolism in pulmonary microsomes and isolated Clara cell populations derived from ozone-exposed rats. J Toxicol Environ Health 24:515-531.
69. Roe AL, Snawder JE, Benson RW, Roberts DW, Casciano DA. 1993. HepG2 cells: an in vitro model for P450-dependent metabolism of acetaminophen. Biochem Biophys Res Commun 190:15-19.
70. Roscher E, Wiebel FJ. 1988. Mutagenicity, clastogenicity and cytotoxicity of procarcinogens in a rat hepatoma cell line competent for xenobiotic metabolism. Mutagenesis 3:269-276.
71. Ryu J, Youn J, Kim Y, Kwon O, Song Y, Kim H, Cho K, Chang I. 1999. Mutation spectrum of 4-nitroquinoline-N-oxide in the lacI transgenic BigBlue® Rat2 cell line. Mutat Res 445:127-135.
72. Ryu JC, Kim YJ, Chai YG. 2002. Mutation spectrum of 1,2-dibromo-3-chloropropane, an endocrine disruptor, in the lacI transgenic BigBlue® Rat2 fibroblast cell line. Mutagenesis 17:301-307.
73. Saranko CJ, Recio L. 1998. The butadiene metabolite, 1,2:3,4-diepoxybutane, induces micronuclei but is only weakly mutagenic at lacI in the BigBlue® Rat2 lacI transgenic cell line. Environ Mol Mutagen 31:32-40.
74. Saranko CJ, Pluta LJ, Recio L. 1998. Molecular analysis of lacI mutants from transgenic fibroblasts exposed to 1,2-epoxybutene. Carcinogenesis 19:1879-1887.
75. Schmezer P, Eckert C, Liegibel UM, Klein RG, Bartsch H. 1998. Use of transgenic mutational test systems in risk assessment of carcinogens. Arch Toxicol 20(suppl):321-330.
76. Shimizu RW, Sun JD, Li AP, Newton GJ, Brooks AL. 1984. The use of sister-chromatid exchange in Chinese hamster primary lung cell cultures to measure genotoxicity. Mutat Res 130:333-342.
77. Suri A, deBoer J, Kusser W, Glickman BW. 1996. A 3 milliTesla 60 Hz magnetic field is neither mutagenic nor co-mutagenic in the presence of menadione and MNU in a transgenic rat cell line. Mutat Res 372:23-31.
78. Suzuki T, Hayashi M, Wang X, Yamamoto K, Ono T, Myhr BC, Sofuni T. 1997. A comparison of the genotoxicity of ethylnitrosourea and ethyl methanesulfonate in lacZ transgenic mice (Muta™Mouse). Mutat Res 395:75-82.
79. Taft SA, Liber HL, Skopek TR. 1994. Mutational spectrum of ICR-191 at the hprt locus in human lymphoblastoid cells. Environ Mol Mutagen 23:96-100.
80. Thapliyal R, Deshpande SS, Maru GB. 2002. Mechanism(s) of turmeric-mediated protective effects against benzo(a)pyrene-derived DNA adducts. Cancer Lett 175:79-88.
81. Ueng TH, Hu SH, Chen RM, Wang HW, Kuo ML. 2000. Induction of cytochrome P-450 1A1 in human hepatoma HepG2 and lung carcinoma NCI-H322 cells by motorcycle exhaust particulate. J Toxicol Environ Health A 60:101-119.
82. van den Heuvel MR, Munkittrick KR. 1995. Second-round interlaboratory comparison of hepatic ethoxyresorufin-O-deethylase activity in white sucker (Catostomus commersoni) exposed to bleached-kraft pulp mill effluent. Environ Toxicol Chem 14:1513-1520.
83. Vijg J, Douglas G. 1996. Bacteriophage lambda and plasmid LacZ transgenic mice for studying mutations in vivo. In: Pfeifer G, editor. Technologies for the detection of DNA damage and mutations. New York: Plenum Press. p 391-410.
84. Watanabe N, Okochi E, Hirayama Y, Shimada Y, Yanagihara K, Yoshida MC, Takahashi S, Mochizuki M, Sugimura T, Nagao M, Ushijima T. 2001. Single nucleotide instability without microsatellite instability in rat mammary carcinomas. Cancer Res 61:2632-2640.
85. Watson DE, Cunningham ML, Tindall KR. 1998. Spontaneous and ENU-induced mutation spectra at the cII locus in BigBlue® Rat2 embryonic fibroblasts. Mutagenesis 13:487-497.
86. White PA. 2002. The genotoxicity of priority polycyclic aromatic hydrocarbons in complex mixtures. Mutat Res 515:85-98.
87. Whong WZ, Stewart JD, Ong T. 1990. Use of rat primary lung cells for studying genotoxicity with the sister-chromatid exchange and micronucleus assays. Mutat Res 241:7-13.
88. Wiebel FJ, Singh J, Schindler E, Summer KH. 1980. UDP-glucuronosyl-, phenol sulfo-, and glutathione-S-transferase activities of mammalian cells in permanent culture. Toxicology 17:123-126.
89. Wyborski DL, Malkhosyan S, Moores J, Perucho M, Short JM. 1995. Development of a rat cell line containing stably integrated copies of a lambda/lacI shuttle vector. Mutat Res 334:161-165.
90. Yamada T, Yamamoto R, Kaneko H, Yoshitake A. 1999. Ethylnitrosourea-induced mutation and molecular analysis of transgenic mice containing the gpt shuttle vector. Mutat Res 441:59-72.
91. You YH, Lee DH, Yoon JH, Nakajima S, Yasui A, Pfeifer GP. 2001. Cyclobutane pyrimidine dimers are responsible for the vast majority of mutations induced by UVB irradiation in mammalian cells. J Biol Chem 276:44688-44694.
92. Zimmer DM, Zhang XB, Harbach PR, Mayo JK, Aaron CS. 1996. Spontaneous and ethylnitrosourea-induced mutation fixation and molecular spectra at the lacI transgene in the BigBlue® rat-2 embryo cell line. Environ Mol Mutagen 28:325-333.